Adjuvante Therapie der Atopischen Dermatitis - Wohlrab-net.de

Störungen der Barrierefunktion beim Atopiker 5
6. Melton JL, Wertz PW, Schwartzendruber DC et al.( 1987) Effects of
essential fatty acid deficiency on O-acyl-sphingolipids and transepidermal
water loss in young pigs. Biochim Biophys Acta 921:191-197
7. Schmuth M, Mao-Qiang M, Weber F et al. (2000) Permeability barrier
disorder in Niemann-Pick disease: sphingomyelin-ceramide processing
required for normal barrier homeostasis. J Invest Dermatol 115:459-466
8. Werner Y, Lindberg M (1985) Transepidermal water loss in dry and
clinically normal skin in patients with atopic dermatitis. Acta Derm
Venereol 65:102-105
9. Thune P (1989) Evaluation of the hydration and water binding capacity in
atopic skin and so-called dry skin. Acta Derm Venereol 144 (Suppl.):133-
135
10. Melnik B, Hollmann J, Plewig G (1988) Decreased stratum corneum
ceramides in atopic individuals – a pathobiochemical factor in xerosis? Br
J Dermatol 119:547-549
11. Imokawa G, Abe A, Jin K, et al. (1991) Decreased level of ceramides in
stratum corneum of atopic dermatitis: an etiologic factor in atopic dry
skin? J Invest Dermatol 96:523-526
12. Yamamoto A, Serizawa S, Ito M, Sato Y (1991) Stratum corneum lipid
abnormalities in atopic dermatitis. Arch Dermatol Res 283:219-223
13. Macheleidt O, Kaiser HW, Sandhoff K (2002) Deficiency of epidermal
protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest
Dermatol 119:166-173
14. Murata Y Ogata J, Higaki Y et al. (1996) Abnormal expression of
sphingomyelin acylase in atopic dermatitis: an etiologic factor for
ceramide deficiency? J Invest Dermatol 106:1242-1249
15. Ohnishi Y, Okino N, Ito M et al. (1999) Ceramidase activity in bacterial
skin flora as a possible cause of ceramide deficiency in atopic dermatitis.
Clin Diagn Lab Immunol 6:101-104
16. Hara J, Higushi K, Okamoto R et al. (2000) High expression of
sphingomyelin deacylase is an important determinant of ceramide
deficiency leading to barrier disruption in atopic dermatitis. J Invest
Dermatol 115:406-413
17. Ishibashi M, Arikawa J, Okamoto R et al. (2003) Abnormal expression of
the novel epidermal enzyme, glucosylceramide deacylase, and the
accumulation of its enzymatic reaction product, glucosylsphingosine, in
the skin of patients with atopic dermatitis. Lab Invest 83:397-408
____________________________________________________________________________
Wohlrab J (ed.): Adjuvante Therapie der Atopischen Dermatitis
In: Trends Clin Exp Dermatol, Aachen, Shaker, 2005, vol 4